(Q46388236)

English

Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18772860

Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients (English)

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18772860

1 reference

based on heuristic

inferred from title

author name string

Anna Fratta Pasini

1

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18772860

Ulisse Garbin

2

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18772860

Chiara Stranieri

3

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18772860

Veronica Boccioletti

4

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18772860

Chiara Mozzini

5

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18772860

Stefania Manfro

6

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18772860

Andrea Pasini

7

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18772860

Mattia Cominacini

8

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18772860

Luciano Cominacini

9

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18772860

publication date

4 September 2008

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18772860

Journal of Clinical Hypertension

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18772860

21

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18772860

1251-1257

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18772860

11

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18772860

Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Testing endothelial vasomotor function: nitric oxide, a multipotent molecule

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture).

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Nebivolol and its 4-keto derivative increase nitric oxide in endothelial cells by reducing its oxidative inactivation

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Nebivolol reduces nitroxidative stress and restores nitric oxide bioavailability in endothelium of black Americans

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms underlying nebivolol-induced endothelial nitric oxide synthase activation in human umbilical vein endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

The cellular mechanisms involved in the vasodilator effect of nebivolol on the renal artery

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Nebivolol Prevents Vascular NOS III Uncoupling in Experimental Hyperlipidemia and Inhibits NADPH Oxidase Activity in Inflammatory Cells

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein methylation.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

34th Bethesda Conference: Task force #3--What is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis?

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in hyperthyroid patients

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Different effect of antihypertensive drugs on conduit artery endothelial function

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

The L-arginine paradox: Importance of the L-arginine/asymmetrical dimethylarginine ratio

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Nebivolol decreases systemic oxidative stress in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Different effects of atenolol and nebivolol on coronary flow reserve

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

ADMA is independently related to flow-mediated vasodilation in subjects at low cardiovascular risk.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of DL-nebivolol, its enantiomers and metabolites on the intracellular production of superoxide and nitric oxide in human endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of Nitric Oxide Release by Nebivolol and Its Metabolites

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta(2)-adrenergic receptor-mediated nitric oxide production

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for an estradiol-agonistic action of nebivolol in spontaneously hypertensive rats.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.260

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/AJH.2008.260

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18772860

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18772860

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46388236&oldid=2109163487"